Sign In

Login

Password

Forgot Password ? Sign Up

ADHD (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "ADHD" in Czech language version.

refsWebsite
Global rank Czech rank
27nih.gov
4th place
8th place
26doi.org
2nd place
4th place
23worldcat.org
5th place
3rd place
6web.archive.org
1st place
1st place
4medicalxpress.com
8,255th place
77th place
3psychiatriepropraxi.cz
low place
1,176th place
3youtube.com
9th place
18th place
2who.int
195th place
168th place
2solen.cz
low place
495th place
2sciencedirect.com
149th place
80th place
2mentalhealthdaily.com
low place
4,960th place
2seznamzpravy.cz
4,711th place
29th place
2wiley.com
222nd place
83rd place
1neurologiepropraxi.cz
low place
1,964th place
1nepozornidospeli.cz
low place
1,202nd place
1russellbarkley.org
low place
low place
1tribune.cz
low place
2,003rd place
1irozhlas.cz
3,217th place
16th place
1nature.com
234th place
72nd place
1szm.sk
low place
4,653rd place
1royalsocietypublishing.org
1,993rd place
321st place
1uhk.cz
low place
1,085th place
1psychiatryadvisor.com
low place
low place
1proquest.com
206th place
2,611th place
1bmj.com
1,226th place
800th place
1vitalia.cz
low place
322nd place
1nzip.cz
low place
919th place
1uzis.cz
low place
568th place
1drmax.cz
low place
low place
1aap.org
low place
low place
1sukl.cz
low place
373rd place
1mediately.co
low place
3,963rd place
1psychscenehub.com
low place
low place
1apa.org
1,220th place
747th place
1psychiatryonline.org
4,032nd place
4,117th place
1elsevier.com
610th place
203rd place

aap.org

publications.aap.org

apa.org

psycnet.apa.org

  • APA PsycNet. psycnet.apa.org [online]. [cit. 2024-01-21]. Dostupné online. (anglicky) 

bmj.com

bmjopen.bmj.com

  • Evidence of potential overdiagnosis and overtreatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents: protocol for a scoping review. bmjopen.bmj.com [online]. [cit. 2024-11-22]. Dostupné online. 

doi.org

dx.doi.org

  • DEMONTIS, Ditte; WALTERS, G. Bragi; ATHANASIADIS, Georgios. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genetics. 2023-02, roč. 55, čís. 2, s. 198–208. Dostupné online [cit. 2023-04-04]. ISSN 1546-1718. DOI 10.1038/s41588-022-01285-8. (anglicky) 
  • NEALE, Benjamin M.; MEDLAND, Sarah E.; RIPKE, Stephan; ASHERSON, Philip; FRANKE, Barbara; LESCH, Klaus-Peter; FARAONE, Stephen V. Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder. S. 884–897. Journal of the American Academy of Child & Adolescent Psychiatry [online]. 2010-09. Roč. 49, čís. 9, s. 884–897. Dostupné online. ISSN 0890-8567. DOI 10.1016/j.jaac.2010.06.008. PMID 20732625. (anglicky) 
  • BARACK, David L.; LUDWIG, Vera U.; PARODI, Felipe. Attention deficits linked with proclivity to explore while foraging. Proceedings of the Royal Society B: Biological Sciences. 2024-02-28, roč. 291, čís. 2017. Dostupné online [cit. 2024-02-21]. ISSN 0962-8452. DOI 10.1098/rspb.2022.2584. (anglicky) 
  • EMOND, V.; JOYAL, C.; POISSANT, H. Neuroanatomie structurelle et fonctionnelle du trouble déficitaire d’attention avec ou sans hyperactivité (TDAH). S. 107–114. L'Encéphale [online]. 2009-04. Roč. 35, čís. 2, s. 107–114. Dostupné online. DOI 10.1016/j.encep.2008.01.005. (francouzsky) 
  • QUINN, Patricia O. Treating adolescent girls and women with ADHD: gender-specific issues. Journal of Clinical Psychology. 2005-05, roč. 61, čís. 5, s. 579–587. PMID: 15723425. Dostupné online [cit. 2023-03-14]. ISSN 0021-9762. DOI 10.1002/jclp.20121. PMID 15723425. 
  • ROBERTS, Bethan; EISENLOHR-MOUL, Tory; MARTEL, Michelle M. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018-02-01, roč. 88, s. 105–114. Dostupné online [cit. 2023-03-04]. ISSN 0306-4530. DOI 10.1016/j.psyneuen.2017.11.015. (anglicky) 
  • HWANG, Wu Jeong; LEE, Tae Young; KIM, Nahrie Suk. The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders. International Journal of Molecular Sciences. 2020-12-31, roč. 22, čís. 1, s. 373. PMID: 33396472 PMCID: PMC7794990. Dostupné online [cit. 2023-03-14]. ISSN 1422-0067. DOI 10.3390/ijms22010373. PMID 33396472. 
  • SNYDER, Steven M.; RUGINO, Thomas A.; HORNIG, Mady. Integration of an EEG biomarker with a clinician's ADHD evaluation. Brain and Behavior. 2015-04, roč. 5, čís. 4. Dostupné online [cit. 2024-07-14]. ISSN 2162-3279. DOI 10.1002/brb3.330. PMID 25798338. (anglicky) 
  • STÁRKOVÁ, Libuše. ADHD in the light of contenporary psychiatry and clinical practice. Pediatrie pro praxi. 2016-02-01, roč. 17, čís. 1, s. 16–21. Dostupné online [cit. 2024-07-14]. ISSN 1213-0494. DOI 10.36290/ped.2016.004. 
  • SOLMI, Marco; FORNARO, Michele; OSTINELLI, Edoardo G. Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects. World Psychiatry. 2020-6, roč. 19, čís. 2, s. 214–232. PMID: 32394557 PMCID: PMC7215080. Dostupné online [cit. 2023-08-26]. ISSN 1723-8617. DOI 10.1002/wps.20765. PMID 32394557. 
  • CORTESE, Samuele; ADAMO, Nicoletta; DEL GIOVANE, Cinzia. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet. Psychiatry. 2018-9, roč. 5, čís. 9, s. 727–738. PMID: 30097390 PMCID: PMC6109107. Dostupné online [cit. 2024-01-21]. ISSN 2215-0366. DOI 10.1016/S2215-0366(18)30269-4. PMID 30097390. 
  • ARNSTEN, Amy F.T. Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species. Neurobiology of Learning and Memory. 2020-12, roč. 176, s. 107327. Dostupné online [cit. 2024-07-20]. ISSN 1074-7427. DOI 10.1016/j.nlm.2020.107327. PMID 33075480. 
  • CHILDRESS, Ann; HOO-CARDIEL, Asmara; LANG, Peter. Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy. 2020-03, roč. 21, čís. 4, s. 417–426. PMID: 31971448. Dostupné online [cit. 2024-01-21]. ISSN 1744-7666. DOI 10.1080/14656566.2019.1706480. PMID 31971448. 
  • NAGEYE, Fatuma; CORTESE, Samuele. Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD. Expert Review of Neurotherapeutics. 2019-07, roč. 19, čís. 7, s. 707–717. PMID: 31167583. Dostupné online [cit. 2024-01-21]. ISSN 1744-8360. DOI 10.1080/14737175.2019.1628640. PMID 31167583. 
  • WANG, Sheng-Min; HAN, Changsu; LEE, Soo-Jung. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Psychiatric Research. 2017-01, roč. 84, s. 292–300. PMID: 27810669. Dostupné online [cit. 2024-01-21]. ISSN 1879-1379. DOI 10.1016/j.jpsychires.2016.09.034. PMID 27810669. 
  • ARNOLD, Valerie K.; FEIFEL, David; EARL, Craig Q. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. Journal of Attention Disorders. 2014-02, roč. 18, čís. 2, s. 133–144. PMID: 22617860. Dostupné online [cit. 2024-01-21]. ISSN 1557-1246. DOI 10.1177/1087054712441969. PMID 22617860. 
  • CHILDRESS, Ann C.; KOMOLOVA, Marina; SALLEE, F. Randy. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology. 2019-11, roč. 15, čís. 11, s. 937–974. PMID: 31581854. Dostupné online [cit. 2024-01-21]. ISSN 1744-7607. DOI 10.1080/17425255.2019.1675636. PMID 31581854. 
  • ALALALMEH, Samer O.; HEGAZI, Omar E.; SHAHWAN, Moyad. Amphetamines in child medicine: a review of ClinicalTrials.gov. Frontiers in Pharmacology. 2023-10-03, roč. 14, s. 1280562. PMID: 37854716 PMCID: PMC10579567. Dostupné online [cit. 2024-01-21]. ISSN 1663-9812. DOI 10.3389/fphar.2023.1280562. PMID 37854716. 
  • WIGAL, Tim L.; NEWCORN, Jeffrey H.; HANDAL, Nelson. A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS drugs. 2018-03, roč. 32, čís. 3, s. 289–301. PMID: 29557078 PMCID: PMC5889769. Dostupné online [cit. 2023-07-06]. ISSN 1179-1934. DOI 10.1007/s40263-018-0503-y. PMID 29557078. 
  • OTASOWIE, John; EHIMARE, Umunoibalo; CHALHOUB, Nevyne. Tricyclic antidepressants for ADHD in children and adolescents. Příprava vydání The Cochrane Collaboration. Chichester, UK: John Wiley & Sons, Ltd Dostupné online. DOI 10.1002/14651858.cd006997. (anglicky) DOI: 10.1002/14651858.CD006997. 
  • DORREGO, María Flavia; CANEVARO, Lilia; KUZIS, Gabriela. A Randomized, Double-Blind, Crossover Study of Methylphenidate and Lithium in Adults With Attention-Deficit/Hyperactivity Disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 2002-08, roč. 14, čís. 3, s. 289–295. Dostupné online [cit. 2024-01-21]. ISSN 0895-0172. DOI 10.1176/jnp.14.3.289. 
  • CHANG, Zheng; GHIRARDI, Laura; QUINN, Patrick D. Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases. Biological Psychiatry. 2019-09, roč. 86, čís. 5, s. 335–343. Dostupné online [cit. 2024-07-13]. DOI 10.1016/j.biopsych.2019.04.009. PMID 31155139. (anglicky) 
  • FARAONE, Stephen V.; BANASCHEWSKI, Tobias; COGHILL, David. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews. 2021-09, roč. 128, s. 789–818. Dostupné online [cit. 2024-06-28]. ISSN 0149-7634. DOI 10.1016/j.neubiorev.2021.01.022. PMID 33549739. 
  • LAM, Alexandra P.; MATTHIES, Swantje; GRAF, Erika. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA network open. 2019-05-03, roč. 2, čís. 5, s. e194980. PMID: 31150084 PMCID: PMC6547099. Dostupné online [cit. 2023-06-03]. ISSN 2574-3805. DOI 10.1001/jamanetworkopen.2019.4980. PMID 31150084. 

doi.org

drmax.cz

  • Možnost objednání Vyvanse(Elvanse). Dr. Max lékárna [online]. 2024 [cit. 2024-05-11]. Dostupné online. 

elsevier.com

linkinghub.elsevier.com

  • CHANG, Zheng; GHIRARDI, Laura; QUINN, Patrick D. Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases. Biological Psychiatry. 2019-09, roč. 86, čís. 5, s. 335–343. Dostupné online [cit. 2024-07-13]. DOI 10.1016/j.biopsych.2019.04.009. PMID 31155139. (anglicky) 

irozhlas.cz

  • Kolaps dětské psychiatrie? Ignorace ministerstva mě šokuje, říká novinářka. iROZHLAS [online]. 2022-12-07 [cit. 2024-12-03]. Dostupné online. 

mediately.co

  • ARGOFAN 150MG Tableta s prodlouženým uvolňováním - Databáze léčiv. Mediately [online]. [cit. 2023-03-04]. Dostupné online. 

medicalxpress.com

  • Study links child behavior problems to prenatal tobacco smoke and traffic density. medicalxpress.com [online]. 2021-04-27 [cit. 2021-11-05]. Dostupné online. (anglicky) 
  • Half of adults with ADHD have had a substance use disorder. medicalxpress.com [online]. 2021-08-25 [cit. 2021-11-05]. Dostupné online. (anglicky) 
  • Study: Researchers find link between plastic additive and autism, ADHD. medicalxpress.com [online]. [cit. 2023-09-29]. Dostupné online. 
  • More sleep could reduce impulsive behavior in children. medicalxpress.com [online]. [cit. 2023-08-29]. Dostupné online. 

mentalhealthdaily.com

  • Provigil For ADHD: Can Modafinil Help Manage Attention-Deficit Hyperactivity Disorder?. mentalhealthdaily.com [online]. 2014-03-17 [cit. 2021-11-05]. Dostupné online. (anglicky) 
  • Wellbutrin (Bupropion) For ADHD and Depression. mentalhealthdaily.com [online]. 2014-04-08 [cit. 2021-11-05]. Dostupné online. (anglicky) 

nature.com

  • DEMONTIS, Ditte; WALTERS, G. Bragi; ATHANASIADIS, Georgios. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genetics. 2023-02, roč. 55, čís. 2, s. 198–208. Dostupné online [cit. 2023-04-04]. ISSN 1546-1718. DOI 10.1038/s41588-022-01285-8. (anglicky) 

nepozornidospeli.cz

neurologiepropraxi.cz

  • CAHOVÁ, Pavlína; PEJČOCHOVÁ, Jana; OŠLEJŠKOVÁ, Hana. Hyperkinetická porucha/ADHD v dospívání a dospělosti: diagnostika, klinický obraz a komorbidity. S. 373–377. Neurologie pro praxi [online]. 2010. Roč. 11, čís. 6, s. 373–377. Dostupné online. 

nih.gov

ncbi.nlm.nih.gov

  • NEALE, Benjamin M.; MEDLAND, Sarah E.; RIPKE, Stephan; ASHERSON, Philip; FRANKE, Barbara; LESCH, Klaus-Peter; FARAONE, Stephen V. Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder. S. 884–897. Journal of the American Academy of Child & Adolescent Psychiatry [online]. 2010-09. Roč. 49, čís. 9, s. 884–897. Dostupné online. ISSN 0890-8567. DOI 10.1016/j.jaac.2010.06.008. PMID 20732625. (anglicky) 
  • QUINN, Patricia O. Treating adolescent girls and women with ADHD: gender-specific issues. Journal of Clinical Psychology. 2005-05, roč. 61, čís. 5, s. 579–587. PMID: 15723425. Dostupné online [cit. 2023-03-14]. ISSN 0021-9762. DOI 10.1002/jclp.20121. PMID 15723425. 
  • HWANG, Wu Jeong; LEE, Tae Young; KIM, Nahrie Suk. The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders. International Journal of Molecular Sciences. 2020-12-31, roč. 22, čís. 1, s. 373. PMID: 33396472 PMCID: PMC7794990. Dostupné online [cit. 2023-03-14]. ISSN 1422-0067. DOI 10.3390/ijms22010373. PMID 33396472. 
  • SNYDER, Steven M.; RUGINO, Thomas A.; HORNIG, Mady. Integration of an EEG biomarker with a clinician's ADHD evaluation. Brain and Behavior. 2015-04, roč. 5, čís. 4. Dostupné online [cit. 2024-07-14]. ISSN 2162-3279. DOI 10.1002/brb3.330. PMID 25798338. (anglicky) 
  • SOLMI, Marco; FORNARO, Michele; OSTINELLI, Edoardo G. Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects. World Psychiatry. 2020-6, roč. 19, čís. 2, s. 214–232. PMID: 32394557 PMCID: PMC7215080. Dostupné online [cit. 2023-08-26]. ISSN 1723-8617. DOI 10.1002/wps.20765. PMID 32394557. 
  • CORTESE, Samuele; ADAMO, Nicoletta; DEL GIOVANE, Cinzia. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet. Psychiatry. 2018-9, roč. 5, čís. 9, s. 727–738. PMID: 30097390 PMCID: PMC6109107. Dostupné online [cit. 2024-01-21]. ISSN 2215-0366. DOI 10.1016/S2215-0366(18)30269-4. PMID 30097390. 
  • ARNSTEN, Amy F.T. Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species. Neurobiology of Learning and Memory. 2020-12, roč. 176, s. 107327. Dostupné online [cit. 2024-07-20]. ISSN 1074-7427. DOI 10.1016/j.nlm.2020.107327. PMID 33075480. 
  • CHILDRESS, Ann; HOO-CARDIEL, Asmara; LANG, Peter. Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy. 2020-03, roč. 21, čís. 4, s. 417–426. PMID: 31971448. Dostupné online [cit. 2024-01-21]. ISSN 1744-7666. DOI 10.1080/14656566.2019.1706480. PMID 31971448. 
  • NAGEYE, Fatuma; CORTESE, Samuele. Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD. Expert Review of Neurotherapeutics. 2019-07, roč. 19, čís. 7, s. 707–717. PMID: 31167583. Dostupné online [cit. 2024-01-21]. ISSN 1744-8360. DOI 10.1080/14737175.2019.1628640. PMID 31167583. 
  • WANG, Sheng-Min; HAN, Changsu; LEE, Soo-Jung. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Psychiatric Research. 2017-01, roč. 84, s. 292–300. PMID: 27810669. Dostupné online [cit. 2024-01-21]. ISSN 1879-1379. DOI 10.1016/j.jpsychires.2016.09.034. PMID 27810669. 
  • ARNOLD, Valerie K.; FEIFEL, David; EARL, Craig Q. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. Journal of Attention Disorders. 2014-02, roč. 18, čís. 2, s. 133–144. PMID: 22617860. Dostupné online [cit. 2024-01-21]. ISSN 1557-1246. DOI 10.1177/1087054712441969. PMID 22617860. 
  • CHILDRESS, Ann C.; KOMOLOVA, Marina; SALLEE, F. Randy. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology. 2019-11, roč. 15, čís. 11, s. 937–974. PMID: 31581854. Dostupné online [cit. 2024-01-21]. ISSN 1744-7607. DOI 10.1080/17425255.2019.1675636. PMID 31581854. 
  • ALALALMEH, Samer O.; HEGAZI, Omar E.; SHAHWAN, Moyad. Amphetamines in child medicine: a review of ClinicalTrials.gov. Frontiers in Pharmacology. 2023-10-03, roč. 14, s. 1280562. PMID: 37854716 PMCID: PMC10579567. Dostupné online [cit. 2024-01-21]. ISSN 1663-9812. DOI 10.3389/fphar.2023.1280562. PMID 37854716. 
  • WIGAL, Tim L.; NEWCORN, Jeffrey H.; HANDAL, Nelson. A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS drugs. 2018-03, roč. 32, čís. 3, s. 289–301. PMID: 29557078 PMCID: PMC5889769. Dostupné online [cit. 2023-07-06]. ISSN 1179-1934. DOI 10.1007/s40263-018-0503-y. PMID 29557078. 
  • CHANG, Zheng; GHIRARDI, Laura; QUINN, Patrick D. Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases. Biological Psychiatry. 2019-09, roč. 86, čís. 5, s. 335–343. Dostupné online [cit. 2024-07-13]. DOI 10.1016/j.biopsych.2019.04.009. PMID 31155139. (anglicky) 
  • FARAONE, Stephen V.; BANASCHEWSKI, Tobias; COGHILL, David. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews. 2021-09, roč. 128, s. 789–818. Dostupné online [cit. 2024-06-28]. ISSN 0149-7634. DOI 10.1016/j.neubiorev.2021.01.022. PMID 33549739. 
  • PACLT, Ivo; PRIBILOVÁ, Nikol; KOLLÁROVÁ, Patricie. Reverse asymmetry and changes in brain structural volume of the basal ganglia in ADHD, developmental changes and the impact of stimulant medications. Neuro Endocrinology Letters. 2016, roč. 37, čís. 1, s. 29–32. PMID: 26994382. Dostupné online [cit. 2023-06-03]. ISSN 0172-780X. PMID 26994382. 
  • LAM, Alexandra P.; MATTHIES, Swantje; GRAF, Erika. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA network open. 2019-05-03, roč. 2, čís. 5, s. e194980. PMID: 31150084 PMCID: PMC6547099. Dostupné online [cit. 2023-06-03]. ISSN 2574-3805. DOI 10.1001/jamanetworkopen.2019.4980. PMID 31150084. 

pubmed.ncbi.nlm.nih.gov

  • QUINN, Patricia O. Treating adolescent girls and women with ADHD: gender-specific issues. Journal of Clinical Psychology. 2005-05, roč. 61, čís. 5, s. 579–587. PMID: 15723425. Dostupné online [cit. 2023-03-14]. ISSN 0021-9762. DOI 10.1002/jclp.20121. PMID 15723425. 
  • CHILDRESS, Ann; HOO-CARDIEL, Asmara; LANG, Peter. Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy. 2020-03, roč. 21, čís. 4, s. 417–426. PMID: 31971448. Dostupné online [cit. 2024-01-21]. ISSN 1744-7666. DOI 10.1080/14656566.2019.1706480. PMID 31971448. 
  • NAGEYE, Fatuma; CORTESE, Samuele. Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD. Expert Review of Neurotherapeutics. 2019-07, roč. 19, čís. 7, s. 707–717. PMID: 31167583. Dostupné online [cit. 2024-01-21]. ISSN 1744-8360. DOI 10.1080/14737175.2019.1628640. PMID 31167583. 
  • WANG, Sheng-Min; HAN, Changsu; LEE, Soo-Jung. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Psychiatric Research. 2017-01, roč. 84, s. 292–300. PMID: 27810669. Dostupné online [cit. 2024-01-21]. ISSN 1879-1379. DOI 10.1016/j.jpsychires.2016.09.034. PMID 27810669. 
  • ARNOLD, Valerie K.; FEIFEL, David; EARL, Craig Q. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. Journal of Attention Disorders. 2014-02, roč. 18, čís. 2, s. 133–144. PMID: 22617860. Dostupné online [cit. 2024-01-21]. ISSN 1557-1246. DOI 10.1177/1087054712441969. PMID 22617860. 
  • CHILDRESS, Ann C.; KOMOLOVA, Marina; SALLEE, F. Randy. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology. 2019-11, roč. 15, čís. 11, s. 937–974. PMID: 31581854. Dostupné online [cit. 2024-01-21]. ISSN 1744-7607. DOI 10.1080/17425255.2019.1675636. PMID 31581854. 
  • WIGAL, Tim L.; NEWCORN, Jeffrey H.; HANDAL, Nelson. A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS drugs. 2018-03, roč. 32, čís. 3, s. 289–301. PMID: 29557078 PMCID: PMC5889769. Dostupné online [cit. 2023-07-06]. ISSN 1179-1934. DOI 10.1007/s40263-018-0503-y. PMID 29557078. 
  • PACLT, Ivo; PRIBILOVÁ, Nikol; KOLLÁROVÁ, Patricie. Reverse asymmetry and changes in brain structural volume of the basal ganglia in ADHD, developmental changes and the impact of stimulant medications. Neuro Endocrinology Letters. 2016, roč. 37, čís. 1, s. 29–32. PMID: 26994382. Dostupné online [cit. 2023-06-03]. ISSN 0172-780X. PMID 26994382. 
  • LAM, Alexandra P.; MATTHIES, Swantje; GRAF, Erika. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA network open. 2019-05-03, roč. 2, čís. 5, s. e194980. PMID: 31150084 PMCID: PMC6547099. Dostupné online [cit. 2023-06-03]. ISSN 2574-3805. DOI 10.1001/jamanetworkopen.2019.4980. PMID 31150084. 

nzip.cz

  • ČR, ÚZIS. ADHD u dětí: příčiny a diagnóza. NZIP.cz [online]. [cit. 2024-02-21]. Dostupné online. 

proquest.com

  • The Danger of ADHD Overdiagnosis. www.proquest.com [online]. [cit. 2024-11-22]. Dostupné online. 

psychiatriepropraxi.cz

psychiatryadvisor.com

  • A True ADHD Epidemic or an Epidemic of Overdiagnosis? [online]. [cit. 2023-10-22]. Dostupné online. 

psychiatryonline.org

neuro.psychiatryonline.org

  • DORREGO, María Flavia; CANEVARO, Lilia; KUZIS, Gabriela. A Randomized, Double-Blind, Crossover Study of Methylphenidate and Lithium in Adults With Attention-Deficit/Hyperactivity Disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 2002-08, roč. 14, čís. 3, s. 289–295. Dostupné online [cit. 2024-01-21]. ISSN 0895-0172. DOI 10.1176/jnp.14.3.289. 

psychscenehub.com

  • Psychopharmacology and Clinical Application of Guanfacine and Clonidine for ADHD - What's the Difference?. Psych Scene Hub [online]. 2024-06-27 [cit. 2024-07-20]. Dostupné online. (anglicky) 

royalsocietypublishing.org

  • BARACK, David L.; LUDWIG, Vera U.; PARODI, Felipe. Attention deficits linked with proclivity to explore while foraging. Proceedings of the Royal Society B: Biological Sciences. 2024-02-28, roč. 291, čís. 2017. Dostupné online [cit. 2024-02-21]. ISSN 0962-8452. DOI 10.1098/rspb.2022.2584. (anglicky) 

russellbarkley.org

sciencedirect.com

  • EMOND, V.; JOYAL, C.; POISSANT, H. Neuroanatomie structurelle et fonctionnelle du trouble déficitaire d’attention avec ou sans hyperactivité (TDAH). S. 107–114. L'Encéphale [online]. 2009-04. Roč. 35, čís. 2, s. 107–114. Dostupné online. DOI 10.1016/j.encep.2008.01.005. (francouzsky) 
  • ROBERTS, Bethan; EISENLOHR-MOUL, Tory; MARTEL, Michelle M. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018-02-01, roč. 88, s. 105–114. Dostupné online [cit. 2023-03-04]. ISSN 0306-4530. DOI 10.1016/j.psyneuen.2017.11.015. (anglicky) 

seznamzpravy.cz

  • „Noví pacienti s novými poruchami.“ Systém dětské psychiatrie se hroutí - Seznam Zprávy. www.seznamzpravy.cz [online]. [cit. 2024-02-21]. Dostupné online. 
  • Epidemie deprese v Česku. Třetině deváťáků by prospěla odborná pomoc - Seznam Zprávy. www.seznamzpravy.cz [online]. [cit. 2024-02-21]. Dostupné online. 

solen.cz

  • MASOPUST ET AL. Diagnostika a farmakoterapie ADHD v dospělosti [online]. Psychiatrie pro praxi, 2014 [cit. 2023-07-30]. Dostupné online. 
  • MASOPUST, Jiří; MOHR, Pavel; ANDERS, Martin. Diagnostika a farmakoterapie ADHD v dospělosti. Psychiatrie pro praxi. 2014-11-01, roč. 15, čís. 3, s. 112–117. Dostupné online [cit. 2024-01-04]. (anglicky) 

sukl.cz

szm.sk

predys.szm.sk

tribune.cz

  • WWW.BENES-MICHL.CZ, Beneš & Michl. Trendy diagnostiky ADHD: lepší rozpoznání, nebo přehnaná diagnostika? | MT. www.tribune.cz [online]. [cit. 2024-02-21]. Dostupné online. 

uhk.cz

kmen.uhk.cz

uzis.cz

mkn10.uzis.cz

  • 10. revize Mezinárodní klasifikace nemocí [online]. Praha: Ústav zdravotnických informací a statistiky ČR 2019, 2020-01-01, rev. 2022-01-01 [cit. 2022-05-30]. Kapitola F90 Hyperkinetické poruchy. Dostupné online. 

vitalia.cz

  • Blbý spratek, jaképak ADHD. Známý psychiatr o současné výchově dětí. www.vitalia.cz [online]. [cit. 2023-11-22]. Dostupné online. 

web.archive.org

who.int

icd.who.int

wiley.com

onlinelibrary.wiley.com

doi.wiley.com

  • OTASOWIE, John; EHIMARE, Umunoibalo; CHALHOUB, Nevyne. Tricyclic antidepressants for ADHD in children and adolescents. Příprava vydání The Cochrane Collaboration. Chichester, UK: John Wiley & Sons, Ltd Dostupné online. DOI 10.1002/14651858.cd006997. (anglicky) DOI: 10.1002/14651858.CD006997. 

worldcat.org

  • DEMONTIS, Ditte; WALTERS, G. Bragi; ATHANASIADIS, Georgios. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genetics. 2023-02, roč. 55, čís. 2, s. 198–208. Dostupné online [cit. 2023-04-04]. ISSN 1546-1718. DOI 10.1038/s41588-022-01285-8. (anglicky) 
  • NEALE, Benjamin M.; MEDLAND, Sarah E.; RIPKE, Stephan; ASHERSON, Philip; FRANKE, Barbara; LESCH, Klaus-Peter; FARAONE, Stephen V. Meta-Analysis of Genome-Wide Association Studies of Attention-Deficit/Hyperactivity Disorder. S. 884–897. Journal of the American Academy of Child & Adolescent Psychiatry [online]. 2010-09. Roč. 49, čís. 9, s. 884–897. Dostupné online. ISSN 0890-8567. DOI 10.1016/j.jaac.2010.06.008. PMID 20732625. (anglicky) 
  • BARACK, David L.; LUDWIG, Vera U.; PARODI, Felipe. Attention deficits linked with proclivity to explore while foraging. Proceedings of the Royal Society B: Biological Sciences. 2024-02-28, roč. 291, čís. 2017. Dostupné online [cit. 2024-02-21]. ISSN 0962-8452. DOI 10.1098/rspb.2022.2584. (anglicky) 
  • QUINN, Patricia O. Treating adolescent girls and women with ADHD: gender-specific issues. Journal of Clinical Psychology. 2005-05, roč. 61, čís. 5, s. 579–587. PMID: 15723425. Dostupné online [cit. 2023-03-14]. ISSN 0021-9762. DOI 10.1002/jclp.20121. PMID 15723425. 
  • ROBERTS, Bethan; EISENLOHR-MOUL, Tory; MARTEL, Michelle M. Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology. 2018-02-01, roč. 88, s. 105–114. Dostupné online [cit. 2023-03-04]. ISSN 0306-4530. DOI 10.1016/j.psyneuen.2017.11.015. (anglicky) 
  • HWANG, Wu Jeong; LEE, Tae Young; KIM, Nahrie Suk. The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders. International Journal of Molecular Sciences. 2020-12-31, roč. 22, čís. 1, s. 373. PMID: 33396472 PMCID: PMC7794990. Dostupné online [cit. 2023-03-14]. ISSN 1422-0067. DOI 10.3390/ijms22010373. PMID 33396472. 
  • SNYDER, Steven M.; RUGINO, Thomas A.; HORNIG, Mady. Integration of an EEG biomarker with a clinician's ADHD evaluation. Brain and Behavior. 2015-04, roč. 5, čís. 4. Dostupné online [cit. 2024-07-14]. ISSN 2162-3279. DOI 10.1002/brb3.330. PMID 25798338. (anglicky) 
  • STÁRKOVÁ, Libuše. ADHD in the light of contenporary psychiatry and clinical practice. Pediatrie pro praxi. 2016-02-01, roč. 17, čís. 1, s. 16–21. Dostupné online [cit. 2024-07-14]. ISSN 1213-0494. DOI 10.36290/ped.2016.004. 
  • F., Rief, Sandra. Nesoustředěné a neklidné dítě ve škole : praktické postupy pro vyučování a výchovu dětí s ADHD. [s.l.]: Portál Dostupné online. ISBN 80-7178-287-4, ISBN 978-80-7178-287-2. OCLC 43613224 
  • SOLMI, Marco; FORNARO, Michele; OSTINELLI, Edoardo G. Safety of 80 antidepressants, antipsychotics, anti‐attention‐deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta‐review of 78 adverse effects. World Psychiatry. 2020-6, roč. 19, čís. 2, s. 214–232. PMID: 32394557 PMCID: PMC7215080. Dostupné online [cit. 2023-08-26]. ISSN 1723-8617. DOI 10.1002/wps.20765. PMID 32394557. 
  • CORTESE, Samuele; ADAMO, Nicoletta; DEL GIOVANE, Cinzia. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. The Lancet. Psychiatry. 2018-9, roč. 5, čís. 9, s. 727–738. PMID: 30097390 PMCID: PMC6109107. Dostupné online [cit. 2024-01-21]. ISSN 2215-0366. DOI 10.1016/S2215-0366(18)30269-4. PMID 30097390. 
  • ARNSTEN, Amy F.T. Guanfacine’s mechanism of action in treating prefrontal cortical disorders: Successful translation across species. Neurobiology of Learning and Memory. 2020-12, roč. 176, s. 107327. Dostupné online [cit. 2024-07-20]. ISSN 1074-7427. DOI 10.1016/j.nlm.2020.107327. PMID 33075480. 
  • CHILDRESS, Ann; HOO-CARDIEL, Asmara; LANG, Peter. Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy. 2020-03, roč. 21, čís. 4, s. 417–426. PMID: 31971448. Dostupné online [cit. 2024-01-21]. ISSN 1744-7666. DOI 10.1080/14656566.2019.1706480. PMID 31971448. 
  • NAGEYE, Fatuma; CORTESE, Samuele. Beyond stimulants: a systematic review of randomised controlled trials assessing novel compounds for ADHD. Expert Review of Neurotherapeutics. 2019-07, roč. 19, čís. 7, s. 707–717. PMID: 31167583. Dostupné online [cit. 2024-01-21]. ISSN 1744-8360. DOI 10.1080/14737175.2019.1628640. PMID 31167583. 
  • WANG, Sheng-Min; HAN, Changsu; LEE, Soo-Jung. Modafinil for the treatment of attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Psychiatric Research. 2017-01, roč. 84, s. 292–300. PMID: 27810669. Dostupné online [cit. 2024-01-21]. ISSN 1879-1379. DOI 10.1016/j.jpsychires.2016.09.034. PMID 27810669. 
  • ARNOLD, Valerie K.; FEIFEL, David; EARL, Craig Q. A 9-week, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy and safety of modafinil as treatment for adults with ADHD. Journal of Attention Disorders. 2014-02, roč. 18, čís. 2, s. 133–144. PMID: 22617860. Dostupné online [cit. 2024-01-21]. ISSN 1557-1246. DOI 10.1177/1087054712441969. PMID 22617860. 
  • CHILDRESS, Ann C.; KOMOLOVA, Marina; SALLEE, F. Randy. An update on the pharmacokinetic considerations in the treatment of ADHD with long-acting methylphenidate and amphetamine formulations. Expert Opinion on Drug Metabolism & Toxicology. 2019-11, roč. 15, čís. 11, s. 937–974. PMID: 31581854. Dostupné online [cit. 2024-01-21]. ISSN 1744-7607. DOI 10.1080/17425255.2019.1675636. PMID 31581854. 
  • ALALALMEH, Samer O.; HEGAZI, Omar E.; SHAHWAN, Moyad. Amphetamines in child medicine: a review of ClinicalTrials.gov. Frontiers in Pharmacology. 2023-10-03, roč. 14, s. 1280562. PMID: 37854716 PMCID: PMC10579567. Dostupné online [cit. 2024-01-21]. ISSN 1663-9812. DOI 10.3389/fphar.2023.1280562. PMID 37854716. 
  • WIGAL, Tim L.; NEWCORN, Jeffrey H.; HANDAL, Nelson. A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD). CNS drugs. 2018-03, roč. 32, čís. 3, s. 289–301. PMID: 29557078 PMCID: PMC5889769. Dostupné online [cit. 2023-07-06]. ISSN 1179-1934. DOI 10.1007/s40263-018-0503-y. PMID 29557078. 
  • DORREGO, María Flavia; CANEVARO, Lilia; KUZIS, Gabriela. A Randomized, Double-Blind, Crossover Study of Methylphenidate and Lithium in Adults With Attention-Deficit/Hyperactivity Disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 2002-08, roč. 14, čís. 3, s. 289–295. Dostupné online [cit. 2024-01-21]. ISSN 0895-0172. DOI 10.1176/jnp.14.3.289. 
  • FARAONE, Stephen V.; BANASCHEWSKI, Tobias; COGHILL, David. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews. 2021-09, roč. 128, s. 789–818. Dostupné online [cit. 2024-06-28]. ISSN 0149-7634. DOI 10.1016/j.neubiorev.2021.01.022. PMID 33549739. 
  • PACLT, Ivo; PRIBILOVÁ, Nikol; KOLLÁROVÁ, Patricie. Reverse asymmetry and changes in brain structural volume of the basal ganglia in ADHD, developmental changes and the impact of stimulant medications. Neuro Endocrinology Letters. 2016, roč. 37, čís. 1, s. 29–32. PMID: 26994382. Dostupné online [cit. 2023-06-03]. ISSN 0172-780X. PMID 26994382. 
  • LAM, Alexandra P.; MATTHIES, Swantje; GRAF, Erika. Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms: Follow-up Analysis of the COMPAS Trial. JAMA network open. 2019-05-03, roč. 2, čís. 5, s. e194980. PMID: 31150084 PMCID: PMC6547099. Dostupné online [cit. 2023-06-03]. ISSN 2574-3805. DOI 10.1001/jamanetworkopen.2019.4980. PMID 31150084. 

youtube.com